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Abstract
Background: The T-box transcription factor Brachyury (T) is essential for formation of the posterior mesoderm and the
notochord in vertebrate embryos. Work in the frog and the zebrafish has identified some direct genomic targets of
Brachyury, but little is known about Brachyury targets in the mouse.
Methodology/Principal Findings: Here we use chromatin immunoprecipitation and mouse promoter microarrays to
identify targets of Brachyury in embryoid bodies formed from differentiating mouse ES cells. The targets we identify are
enriched for sequence-specific DNA binding proteins and include components of signal transduction pathways that
direct cell fate in the primitive streak and tailbud of the early embryo. Expression of some of these targets, such as Axin2,
Fgf8 and Wnt3a, is down regulated in Brachyury mutant embryos and we demonstrate that they are also Brachyury
targets in the human. Surprisingly, we do not observe enrichment of the canonical T-domain DNA binding sequence 59-
TCACACCT-39 in the vicinity of most Brachyury target genes. Rather, we have identified an (AC)n repeat sequence, which
is conserved in the rat but not in human, zebrafish or Xenopus. We do not understand the significance of this sequence,
but speculate that it enhances transcription factor binding in the regulatory regions of Brachyury target genes in
rodents.
Conclusions/Significance: Our work identifies the genomic targets of a key regulator of mesoderm formation in the early
mouse embryo, thereby providing insights into the Brachyury-driven genetic regulatory network and allowing us to
compare the function of Brachyury in different species.
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Introduction
Brachyury (T) is expressed in the primitive streak, tailbud and
notochord of the early mouse embryo [1,2]. It plays a key role in
early development: mouse embryos lacking functional Brachyury
protein do not gastrulate properly, fail to form a differentiated
notochord, lack structures posterior to somite seven, and have
defects in left-right patterning [3,4,5]. The expression patterns of
the Xenopus [6] and zebrafish [7,8] Brachyury orthologues resemble
those of the mouse, and these genes play similar roles in early
development [8,9,10,11], indicating that Brachyury function has
been conserved throughout evolution.
In an effort to understand how Brachyury exerts its effects, we
have searched for genomic targets of this transcription factor. In
previous work using Xenopus embryos we have used differential
screening approaches to isolate target genes such as eFGF [12],
members of the Bix family [13,14] and Wnt11 [15], while a
chromatin immunoprecipitation-microarray (ChIP-chip) ap-
proach in the zebrafish embryo has allowed us to identify more
than 200 potential targets of No-tail a (Ntla), the orthologue of
Brachyury [16]. In this paper, we apply a ChIP-chip approach to
identify targets of Brachyury during mouse embryonic stem (ES)
cell differentiation. ES cells provide an abundant source of
material as they differentiate towards embryoid bodies (EBs), and
we predict that the identification of Brachyury targets in these
cells will shed light on ES cell differentiation as well as help
identify such targets in the early embryo. This work might also
indicate the extent to which the biological function of Brachyury
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how Brachyury binding motifs are disposed within target cis-
regulatory regions.
Our results show that Brachyury targets in differentiating ES
cells are enriched for sequence-specific DNA binding proteins
and components of signal transduction pathways that direct cell
fate in the primitive streak and tailbud of the early embryo.
Interestingly, most binding peaks were not enriched for the
canonical T-box binding site 59-TCACACCT-39 [17,18] but
did contain a repeating AC motif. Amongst the signal
transduction pathway components were regulators of the
WNT and FGF pathways. These include Axin2 (Axil/Conductin),
which encodes a negative regulator of Wnt signalling, as well as
Wnt3a and Fgf8. Significantly, expression of all three genes is
down regulated in homozygous Brachyury mutant embryos and
we show by ChIP-qPCR that these are also genomic targets of
BRACHYURY in differentiating human ES cells. These results
are consistent with work in the zebrafish emphasising the
importance of Wnt and Fgf signal transduction pathway
components as Brachyury targets [16]. In demonstrating that
expression of Axin2 in the early mouse embryo is regulated by
Brachyury as well as by TCF/Lef proteins [19,20,21,22], our
results emphasise the complex interplay between signalling
pathways in the regulation ofg e n ee x p r e s s i o ni nt h ee a r l y
embryo.
Results
ES cell culture
Preliminary experiments demonstrated that our ES cell culture
regime yielded embryoid bodies of uniform size, similar to that of
EBs grown on hydrophobic surfaces [23], and that expression of
Brachyury usually peaked at day 4 of differentiation (Fig. 1).
Immunohistochemical analysis indicated that approximately 15%
of cells in our embryoid bodies express Brachyury (data not
shown).
ChIP-chip and bioinformatic analysis
Binding sites of Brachyury were identified by ChIP-chip
experiments and the closest gene was identified using version
NBI35.1 of the annotated mouse genome (see Material and
Methods). Following filtration, our analysis gave a list of 520
enriched probes representing 396 genes (Table S1). Genomic
quantitative PCR on a selection of genes called as bound or
unbound confirmed that our ChIP-chip approach identified
genuine binding events (Fig. S1).
Brachyury is expressed at its highest levels in the primitive streak
and haematopoietic progenitors at E7.5 to E8.5. Later expression
is restricted to the tailbud and notochord (E12.5), and then to
parts of the brain and tail [2]. Of the Brachyury targets identified
in our embryoid body experiments whose expression patterns are
known, most (63%) are activated during this period of 7.5 to
17.5 dpc of mouse development (Fig. 2A). And of these 250
genes, many are restricted to the primitive streak or its
mesodermal derivatives, with 30% (75 transcripts) expressed
exclusively in the mesoderm (Fig. 2A). In addition to Axin2, Wnt3a
and Fgf8, which are discussed below, genes that have been
reported to be co-expressed with Brachyury include Msgn1, whose
expression is down regulated in Brachyury mutants [24], Meis1 [25]
Trim 28 [26] and Zic2 [27], which are expressed in the primitive
streak during gastrulation, Foxa2,p r e s e n ti nt h en o d ea n d
notochord [28], and Adam19 (meltrin beta), present in tailbud
mesenchyme [29]. These and other transcripts (see below) are
also co-expressed with Brachyury (or are activated shortly after
Brachyury) in embryoid bodies, and typical profiles of Msgn1, Meis1
and Foxa2 expression are shown in Fig. 2B.
The targets we identify include components of the WNT,
MAPK, JNK, TGF-b, Hedgehog, FGF and G-protein coupled
signal transduction pathways (Table S2). Analysis of the targets
yielded a set of gene ontology (GO) terms consistent with the
function of Brachyury during gastrulation [30].
In particular, cellular component analysis highlights gene
products involved in morphogenesis, cell adhesion and cell
Figure 1. Temporal expression pattern of Brachyury during early ES cell differentiation. The graph shows a quantitative RT-PCR profile
from an embryoid body spinner culture. Brachyury expression is calculated relative to beta actin. Images show undifferentiated R1 cells on mouse
embryo fibroblast feeders at day 0, early blast colonies at day 2, and embryoid bodies at days 3, 4 (when they are cross-linked) and 5.
doi:10.1371/journal.pone.0033346.g001
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morphogenesis (Fig. S2A: GO:0048598; P,10
26), Gabra1, Gfra3
and Cbln3 are involved in anchoring the plasma membrane to
cytoskeletal proteins (Fig. S2B: GO:0030054; P=1610
23) and
others encode proteins involved in cell adhesion, such as the
glycosyltransferases B4galnt2 and Cml4/Nat8. This last observation
is consistent with data showing that glycosyltransferases, and
especially galactotransferases, are mis-expressed in T/T mutant
mice [31], that the extracellular matrix is reduced in such embryos
[32], and that cells have fewer cytoplasmic processes, especially in
the somites and mesenchyme [32]. Significantly, over-expression
of Cml4, or its Xenopus orthologue Camello (Xcml), inhibits
gastrulation in Xenopus [33].
Interestingly, another group of targets is associated with germ
cells (Table S3), including Asap1 (Ddef1), which encodes an ADP-
ribosylation factor GTPase-activating protein implicated in
metastatic prostate cancer [34], and also the Wilms’ tumour gene
WT1 [35].
Transcription factor targets
Of the 396 genes identified as potential targets of Brachyury,
53 (13.4%) are transcription factors (Table S4), and indeed gene
ontology analysis demonstrates significant enrichment for
sequence-specific DNA binding proteins (Fig. S2C
GO:0043565, p,10
25). Several families of transcription factors
are represented, including the Ets, paired box, homeobox,
winged helix/forkhead, bZip and zinc finger families. Under our
ES cell culture conditions, expression of many of these
transcription factors peaks either at the same time as Brachyury
(Foxa2, Foxe1)o rj u s ta f t e r w a r d s( BapX1, Ebf2, Erg, Hoxa13, Meis1,
Msgn1, Nkx2.6 and Slug) (Fig. 2B). As we discuss below, our data
provide a basis for deciphering the transcription factor genetic
regulatory network underlying mesoderm formation in ES cells
and in the embryo.
T-box protein binding motifs
Previous work indicates that Brachyury interacts with the
sequence 59-TCACACCT-39 [16,36,37,38]. To our surprise,
neither nested MICA nor RSAT identified this motif as
significantly enriched in the DNA sequences selected in our
experiments. Rather, both packages identified enrichment of the
simple sequence repeat (AC)n (Fig. S3A). However, although it was
not enriched, we did observe that several regulatory regions
contain a sequence resembling a T-box site (in which 1 to 3
nucleotides differ from the consensus) close to an AC repeat. These
genes include Axin2, Ctnnb1/b-catenin, Erg, Etv1, Fgf8, Fev, Foxa2,
Foxe1, Fyb, Id4, Meis1, and Hoxa3 where the T-box like sites may be
positioned either 59 or 39 to the repeat sequence.
To assess the significance of these observations we first
performed electrophoretic mobility shift assays (Fig. S3B). As
expected, the T-domain of mouse Brachyury binds the canonical
TCACACCT sequence, binding can be competed by unlabelled
oligonucleotide, and the complex can be ‘super-shifted’ by a
Brachyury antibody. The (AC)n repeat motif also forms a
complex with Brachyury, but although the complex can also be
‘supershifted’, unlabelled oligonucleotide competes very poorly.
Finally, when both motifs are present in the radiolabelled
oligonucleotide, competition using an excess of cold oligonucle-
otide in which just the T-box site is mutated is poor, and so is
competition in which just the (AC)n region is mutated. Together,
these observations indicate that the (AC)n sequence interacts only
weakly with Brachyury, if at all, and that its role may be
restricted to stabilizing binding to an adjacent or even a distant
Tb o xs i t e .
If true, such a role is likely to be restricted to rodent species.
Our dataset contains 111 peaks with associated AC repeats
longer than eight nucleotides (Table S5). Comparison with rat,
human, zebrafish and Xenopus genomes shows that 38 of these
AC-rich regions are unique to the mouse while 68 are also
present in the rat. Sixteen of the AC repeats are present in the
human genome, of which 11 are also present in rat. However,
none of the repeats are conserved in zebrafish or Xenopus
(Table S5).
Axin2 and Wnt3a as targets of Brachyury
Amongst the identified Brachyury targets are many genes
encoding positive and negative regulators of the Wnt signalling
pathway (Fig. 3A). Enrichment peaks in the promoter regions of
Dkk1, Ctnnb1/b-catenin, Dvl3, and c-catenin/Jup show Brachyury
binding (Fig. 3B, C, D and E) and also reveal the presence of AC
repeats (green bars) and imperfect T-binding sites (blue bars). Of
these Wnt-related genes, Wnt3a and Axin2 both show strong
Brachyury binding peaks around their transcription start sites in
our ChIP-chip analyses (Figs. 4A, 5A), and their temporal
expression patterns both resemble that of Brachyury in our
embryoid body system (Figs. 4B, 5B). For Wnt3a, a variant
Brachyury site is positioned close to an AC repeat sequence in the
first intron, and a canonical TCACACCT Brachyury site is
upstream of the transcription start site (Fig. 4A). In the case of
Axin2, a canonical Brachyury site is positioned close to a variant
site and to an AC repeat (Fig. 5A).
To ask whether Brachyury is required for expression of
Wnt3a and Axin2,w ec r o s s e dm i c et h a ta r eh e t e r o z y g o u sf o ra
Brachyury mutation [39] and assessed expression of the two
genes. In wild-type embryos at E7.5 the expression patterns of
Brachyury, Wnt3a and Axin2 overlap significantly (Fig. S4).
Expression of Wnt3a in Brachyury homozygous mutant embryos
at this stage resembles that in heterozygous and wild type
individuals, as has been reported previously [40], but by E8.5,
when Wnt3a expression is restricted to the primitive streak, its
expression is significantly down regulated in Brachyury mutant
embryos (Fig. 4C,D).
Like Wnt3a, Axin2 is expressed in Brachyury mutant embryos at
7.5 dpc, but this expression is more variable than that of Wnt3a,
and is sometimes reduced or even absent (data not shown). By
E8.5, when Axin2 is expressed in the headfold, tailbud and
primitive streak of wild type embryos, its expression in the
posterior region of Brachyury mutant embryos is very weak or
absent (Fig. 5C,D). Together, these data indicate that Brachyury is
Figure 2. Analysis of Brachyury targets. (A) Pie chart showing the times in development at which Brachyury target gene expression begins in
the mouse embryo (as a percentage of total; n=396). Most genes (63%) start to be expressed between E7.5, when Brachyury is expressed in the
primitive streak, notochord and tailbud, and E17.5, when expression is restricted to trunk mesenchyme. Of targets showing this temporal expression
pattern, 30% are restricted to mesodermal derivatives, as indicated in the bar chart to the right. Others are expressed in various combinations of
ectoderm, mesoderm and endoderm. (B) Temporal expression of transcription factor targets of Brachyury during ES cell differentiation in spinner
culture, obtained by RT-PCR. The three panels in the top row were taken from a batch of cells in which Brachyury expression peaked at day 4 of
culture; the rest were taken from a batch in which Brachyury expression peaked at day 3. All show means of triplicate measurements and are
normalised to levels of beta actin. Foxa2 and Foxe1 in the top row peak with Brachyury at day 4; genes in the lower panel peak later than Brachyury.
doi:10.1371/journal.pone.0033346.g002
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33346Figure 3. Components of the Wnt pathway as Brachyury targets. (A) The Wnt signalling pathway. Arrows indicate positive interactions and
bars represent negative interactions. Targets identified in this study are outlined in bold. (B–E) Brachyury binding in genomic regions around Dkk1
(B); Ctnnb1/b-catenin (C); Dvl3 (D); and c-Catenin/jup/plakoglobin (E). Each target shows fold enrichment against chromosomal position. Blue bars
represent the T box-like site TSACANNT (N=any base, S=G/C) and green bars represent (AC)n. Stars above bars represent sequence on the reverse
strand. Plots are average of triplicate chip results, aligned to the mm8 Feb. 2006 assembly.
doi:10.1371/journal.pone.0033346.g003
Figure 4. Analysis of Wnt3a, a positive regulator of the Wnt pathway. (A) Location analysis of Wnt3a. The figure (and Figs. 5, 6) shows fold
enrichment against chromosomal position. Plot is the mean of triplicate chip results, aligned to the mm8 Feb. 2006 assembly. Blue bars represent the
T box-like site TSACANNT (N=any base, S=G/C); green bars represent (AC)n; red bars the consensus TCACACCT. Stars above bars represent sequence
on reverse strand. (B) Quantitative RT-PCR expression profile for Wnt3a during ES cell differentiation, expressed relative to beta actin. (C, D) Expression
of Wnt3a studied by in situ hybridisation; in each, the top image shows a dorsal view, and the bottom image a lateral view. (C) Phenotypically wild
type (+/+ or +/T) embryo at E8.5–8.75, and (D) a mutant (T/T) embryo from crosses of Brachyury heterozygous mutant mice. Wnt3a expression is
detected with NBT/BCIP (purple) and the insets show a lateral view after double staining for Brachyury detected with INT/BCIP (orange brown). Note
that in the wild type embryo Wnt3a is expressed in tailbud and paraxial mesoderm. In the mutant embryo expression of Wnt3a staining is absent or
greatly reduced (n=3). Scale bars indicate 250 mm.
doi:10.1371/journal.pone.0033346.g004
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encode key components of the WNT signalling pathway (see
Discussion).
Fgf8 as a target of Brachyury
A strong Brachyury binding peak was also detected 59 of the
transcription start site of Fgf8 (Fig. 6A), with a variant Brachyury
site (59-TCACAGAT-39; underlined bases differ from consensus)
positioned 63 nucleotides from an (AC)19 repeat. The temporal
expression profile of Fgf8 resembles that of Brachyury during
embryoid body differentiation (Fig. 6B), and the gene is co-
expressed with Brachyury in the primitive streak of embryos at E7.5
and E8.0–E8.25 (Fig. S5; Fig. 6C). Expression of Fgf8 in mutant
Brachyury embryos at E8.0 is greatly reduced (Fig. 6C), indicating
that Brachyury is required for expression of this gene as it is for
Wnt3a and Axin2.
Figure 5. Analysis of Axin2, a negative regulator of the Wnt pathway. (A) Location analysis of Axin2. For details see legend to Fig. 4. (B)
Quantitative RT-PCR expression profile for Axin2 during ES cell differentiation, expressed relative to beta actin. (C, D) Expression of Axin2 studied by in
situ hybridisation; in each, the top image shows a dorsal view, and the bottom image a lateral view. (C) Phenotypically wild type (+/+ or +/T) embryo
at E8.5–8.75 and (D) a mutant (T/T) embryo, both derived from crosses of Brachyury heterozygous mutant mice. Axin2 expression is detected with
NBT/BCIP (purple) and the insets show a lateral view after double staining for Brachyury detected with INT/BCIP (orange brown). Note that in the wild
type embryo Axin2 is expressed in tailbud, paraxial mesoderm and lateral margin of the neural folds. In the mutant embryo expression of Axin2 is
greatly reduced (n=9). Scale bars are 250 mm.
doi:10.1371/journal.pone.0033346.g005
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33346Figure 6. Fgf8 as a target of Brachyury. (A) Location analysis of Fgf8. For details of methods see legend to Fig. 4. (B) Quantitative RT-PCR
expression profile for Fgf8 during ES cell differentiation, expressed relative to beta actin. (C) Expression of Fgf8 studied by in situ hybridisation. The
images show a phenotypically wild type (+/+ or +/T) embryo (top pair) and a mutant T/T (bottom pair) embryo derived from crosses of Brachyury
heterozygous mutant mice. The wild type embryo is orientated with anterior to the left and posterior to the right; the mutant is viewed from the
posterior. Fgf8 expression is detected with NBT/BCIP (purple) and Brachyury with INT/BCIP (orange brown). In the wild type embryo Fgf8 is expressed
in the primitive streak and paraxial mesoderm; such expression is absent or greatly reduced in the mutant. Scale bars indicate 200 mm.
doi:10.1371/journal.pone.0033346.g006
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BRACHYURY in the human
Because some of the Brachyury targets we discovered in the
mouse were not previously identified in the frog or the zebrafish
[16], we decided to investigate whether these are conserved in
other species, in an attempt to further validate our results. For this
purpose we decided to look for BRACHYURY binding in the
human genome.
We have recently optimised culture conditions that cause
human embryonic stem cells to differentiate into mesoderm-like
cells [41]. These cell populations express BRACHYURY at high
levels and, importantly, they also up regulate other mesoderm
markers, including many of the Brachyury targets we have
identified in the mouse, namely, DKK1, HOXA13, ID4, JUP,
KRT8, MEIS1, MSGN1, SNAI2, and WNT3A.
We therefore made use of this newly developed in vitro
differentiation system to ask if BRACHYURY binds the homologous
human regulatory regions of some key mouse targets: AXIN2, FGF8,
JUP and WNT3A. As in the mouse, these regions contain imperfect
T-binding motifs (data not shown). Our experiments involving ChIP-
qPCR with hESC-derived mesoderm cells indeed detected a strong
enrichment for these sequences, thus indicating that BRACHYURY
binds to the same genomic regions in the human (Fig. 7A).
Interestingly, these promoter sequences seem to be conserved
between the mouse and human genomes, but not in the zebrafish
or in other vertebrates (Fig. 7B) suggesting that these targets might
be unique to mammals.
Discussion
We have identified genomic targets of Brachyury in differen-
tiating mouse ES cells, demonstrating that embryoid bodies
provide sufficient material for chromatin immunoprecipitation
experiments and that they represent an effective model of early
mouse development. Although they do not undergo proper
morphogenesis, they do generate pattern, as illustrated by the
formation of beating cardiomyocytes [42]. The embryoid bodies
produced in our experiments form cardiomyocytes after eight to
ten days in culture, close to the time at which the heart tube forms
during normal development. As discussed below, at least three
Brachyury targets (Wnt3a, Axin2 and Fgf8) are expressed in the
early mouse embryo during formation of the primitive streak, and
their proper expression during development requires Brachyury
function. We also note that several targets are expressed in
primordial germ cells, perhaps the first differentiated population to
emerge during early gastrulation [43,44,45]. These cells express
Brachyury until E12.5, when the gene is down regulated in a non-
migrating population [46,47]. Although Brachyury may not be
involved directly in the specification of the germ cells [48,49] it
may regulate their migration and their potency.
Classification of Brachyury targets and comparison with
zebrafish and frog
Our work has identified 396 potential targets of Brachyury, and
gene ontology analysis indicates that many of these encode
sequence-specific DNA binding proteins and proteins involved in
cell adhesion and embryonic morphogenesis. Analysis of the
former category will help in the elucidation of the genetic
regulatory network that underlies mesoderm formation (see
below). The latter category includes cell junction proteins and
glycosyltransferases [31], consistent with the finding that the
extracellular matrix of homozygous mutant Brachyury mouse
embryos is poorly developed [32] and that cells have fewer
Figure 7. Conservation of BRACHYURY binding in the human genome. (A) ChIP-qPCR performed on samples from differentiated hECSs
using a specific anti-BRACHYURY IgG and a non-specific control IgG. Graph shows enrichment for regulatory regions of Brachyury targets (AXIN2,
FGF8, JUP, WNT3A) and a negative control region (NCAPD2). Results are expressed relative to input chromatin divided by the enrichment for the non-
specific control antibody. (B) BRACHYURY binding in the human genome. The short red lines below the chromosomal coordinates (hg19) depict the
position of the PCR amplicons relative to the beginning of the human genes (blue). The three bottom tracks show the genome sequence
conservation between human and mouse, zebrafish and vertebrate genomes (Genome Browser, http://genome.ucsc.edu/).
doi:10.1371/journal.pone.0033346.g007
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of mutant cells to move out of the primitive streak and to the
failure of elongation of the antero-posterior axis [30]. Amongst the
other genes regulated by Brachyury are those encoding cytokines
and components of signal transduction pathways, and in most of
these respects our results are reminiscent of those obtained in
similar experiments using the zebrafish embryo [16].
It is significant that embryoid bodies resemble developing
embryos in this way, and it is also important to note the overlap
between the Brachyury targets identified in this study and the Ntl
targets identified in the zebrafish [16]. Both studies identified
transcriptional regulators as being enriched, including members of
the homeobox, winged helix, paired box, zinc finger and odd-
paired families. There are also similarities in the functions of genes
regulated by the two orthologues. These functions include
gastrulation (where the zebrafish study identified wnt11, snail1a
and blf and this analysis Wnt3a, Snail2 and genes such as Gdf5, Etv1,
Krt5, Krt8, Lmx1b, Syk, and Gnaq); muscle specification (where both
studies identified Msgn1 and Pax3); posterior identity (where the
zebrafish study identified fgfr4, fgfr28, vent, vox, and notch3 and this
analysis Fgf8 [50]) and left-right patterning (zebrafish genes include
cx43.4 [51] and our mouse targets Rttn [52], Fgf8 [53], and
cytoplasmic dyneins Dync1li1, Dync2li1 [54] and Dpcd [55]).
The fact that there are some differences between the mouse and
zebrafish targets may derive from the presence of an additional
Brachyury gene in the zebrafish genome [8] or from the ‘sharing’ of
gene function between different T box family members. For
example, the Bix genes were identified as targets of Brachyury and
VegT in Xenopus [13,14], but their mouse ortholog Mixl1 seems to
be regulated mainly by Eomesodermin [56,57]. Furthermore, as
illustrated in Fig. 7B, some regulatory sequences of mammalian
genes (Axin2, Fgf8, Jup and Wnt3a) share little homology with those
of their zebrafish orthologues. It is possible that Brachyury binds
different locations in different genomes, which has been noted for
other transcription factors [58], despite target conservation. It is
also likely that Brachyury binds not only to promoters near the
gene transcription start site but also to distant enhancers [59],
which is indeed the case in the human genome (T. Faial et al., in
preparation). We note that both the mouse and zebrafish arrays
were based on promoter regions, so that enhancer binding is not
available in these datasets, perhaps explaining why some targets
seem to be unique to each species.
Canonical and non-canonical T-box binding sites
Our previous work searching for targets of zebrafish Ntl showed
that the canonical T-box site TCACACCT was enriched in the
vicinity of Ntl target genes [16]. A significant enrichment of this
motif was not observed in the present experiments for the majority
of targets. Rather, we identified a novel (AC) n repeat sequence
that recognised, albeit weakly, the Brachyury T domain in
electrophoretic mobility shift experiments. We do not yet fully
understand the significance of this observation. Mouse Brachyury
binds to an imperfect T-box site palindrome in the Nanog promoter
[60], but no other Brachyury target has been characterised in any
detail in this species. It is possible that mouse Brachyury resembles
Drosophila Brachyenteron, where modular variations on the T-box
consensus binding sequence determine the degree of transcrip-
tional activation [61]. A similar system controls notochord
formation in Ciona, with regulatory motifs comprising Ci-
Brachyury and Ci-foxA binding sites [62].
Moreover, many transcription factors bind directly to DNA in
distal enhancer elements [59], and are then linked to the promoter
region by chromatin looping, allowing interaction with other
proteins involved in transcription regulation [59]. It is likely that in
some mouse targets, canonical Brachyury binding motifs are not
present in the promoter region but rather in upstream or
downstream regulatory regions. Our results show that this does
occur in the human genome (T. Faial et al., in preparation).
It is also possible that the AC repeats cause the transient
formation of left handed DNA helices and bends, changing the
chromatin architecture and encouraging transcription factor
binding [63]. Brachyury may be an example of a protein with a
secondary recognition motif [64] and that the presence of both an
AC repeat and a TCACACCT sequence allows stable binding
that cannot be competed by an excess of just the TCACACCT
sequence (Fig. S3B). Repetitive sequences may also function as
pre-sites; that is, as regions of DNA that are predisposed to evolve
into new regulatory sequences [65].
Brachyury modulation of Wnt and Fgf signalling
Several components of the Wnt signal transduction pathway
were identified as Ntl targets in the zebrafish, and we find that the
same is true for Brachyury in the mouse. In an effort to determine
whether Brachyury regulates expression of these potential targets
during normal mouse development we asked whether Wnt3a and
Axin2 are expressed normally in Brachyury homozygous mutant
embryos, and found that although both genes are expressed at
E7.5 (albeit rather variably in the case of Axin2), neither is
expressed at E8.5 in mesodermal derivatives (Figs. 4, 5). This
suggests that Brachyury is not required for the initial activation of
Wnt3a or Axin2, but is needed for maintenance of their expression.
Together with the observation that Wnt3a maintains Brachyury
expression in the early mouse embryo via TCF/Lef signalling
[20,21], and that Axin2 is down regulated in Wnt3a mutants [66],
our data indicate that Brachyury and Wnt signalling cooperate to
create a regulatory network that specifies the formation of
posterior mesoderm in the mouse embryo.
Part of this network may involve Fgf signalling. Brachyury and
Fgf signalling form part of an autoregulatory loop in Xenopus and
zebrafish embryos [67,68,69,70], and we note that Fgf8 is a target
of Brachyury in embryoid bodies, and that its expression is down
regulated in Brachyury mutant embryos (Fig. 6).
Finally, our work reveals that the promoter regions of AXIN2,
FGF8 and WNT3A are also bound by BRACHYURY (Fig. 7A) in
human ES cells as they differentiate into mesoderm-like cells [41].
These results further substantiate the identity of these genes as bona
fide Brachyury targets and suggest that the regulation of these key
signalling components is conserved during human development.
Making a genetic regulatory network for mesoderm
Attempts to understand the Brachyury genetic regulatory
network are important not only because Brachyury is required
for proper formation of mesoderm in the vertebrate embryo, but
because it is sufficient for the formation of some mesodermal cell
types, at least in Xenopus [71]. The identification of new Brachyury
targets will enable the integration of Brachyury with other
components of genetic regulatory networks that include it, such
as the Ets family member Elk-1 and the caudal homologue, Cdx2
[72] and to ask to what extent such networks have been conserved
during evolution.
Materials and Methods
Ethics statement
Animal procedures were performed under a UK Home Office
project license within the conditions of the Animals (Scientific
Procedures) Act 1986.
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Embryonic stem (ES) cell culture was as described [73] except
that mitotically inactivated primary mouse embryonic fibroblasts
(MEFs) were used as feeders. Culture dishes were coated with
0.1% gelatin (Sigma-Aldrich). MEFs and ES cells were maintained
in DMEM (Sigma-Aldrich) supplemented with 0.1 mM b-
mercaptoethanol, non-essential amino acids (Gibco Invitrogen),
2 mM glutamate (Gibco Invitrogen), and batch-tested 10%
(MEFs) or 15% (ES cells) foetal bovine serum (FBS) (Gibco
Invitrogen). ES cell medium was also supplemented with
Leukaemia Inhibitory Factor (LIF) (ESGROH, Millipore) at 10
3
units/ml [74]. Early passage R1 mouse ES cells [75] were
passaged every 2 days and medium was changed daily to prevent
differentiation.
ES cells were differentiated in spinner flasks to produce large
numbers of embryoid bodies (EBs) undergoing synchronized
differentiation [76,77]. The Cellspin culture system (Integra
Biosciences) was set at 25 rpm and spin angle 720u so as to avoid
aggregation of EBs. Spinner medium was prepared as above, but
with LIF omitted and FBS increased to 20%. On day 0, adherent
log phase ES cell colonies were dissociated and resuspended in
10 ml spinner medium. Feeder cells were depleted by differential
sedimentation at 37uC for 20 min.
Medium (45 ml) was pre-equilibrated in 100 ml silicon-coated
(Sigmacote, Sigma-Aldrich) spinner flasks (Integra Biosciences). ES
cells were recovered from the gelatin-coated differential sedimen-
tation plates and centrifuged at 800 g for 5 min. Cells were fully
dissociated to ensure that cultures were initiated from single cells,
and each spinner flask was inoculated with 10
7 cells in 5 ml
medium. After 24 h (day 1 of differentiation) a further 50 ml
spinner medium was added to each flask. Each day thereafter EBs
were allowed to sink and 50 ml medium was aspirated and
replaced with 50 ml fresh pre-warmed spinner medium.
Human ESC culture
Human ESCs (H9 [WiCell, Madison, WI]) were maintained
and differentiated as previously described [41]. Briefly, hESCs
were induced to express BRACHYURY by culturing them in a
chemically defined medium (CDM) supplemented with FGF2
(20 ng/ml), LY294002 (10 mM) and BMP4 (10 ng/ml) (termed
FLyB medium). Cells were collected for ChIP after 36 h of culture
in FLyB medium, when BRACHYURY expression peaked.
Quantitative RT-PCR
Gene expression was analysed by real-time RT-PCR. RNA was
isolated from differentiated EBs using Tri-Reagent LS (Sigma-
Aldrich), digested with DNA-free DNAse I (Ambion), and checked
for integrity using an Agilent Technologies 2100 Bioanalyser.
cDNA was generated from l mg RNA using Superscript III Reverse
Transcriptase (Invitrogen, Life Technologies), and this was followed
by real-time PCR using the LightCycler 480 SYBR Green I master
kit (Roche). Mouse beta actin primers were used as an endogenous
control to express relative expression levels (Table S6).
Antibodies
Several anti-Brachyury antibodies were tested for use in this
work. Of these, the goat polyclonal C19 antibody (SC-17745,
Santa Cruz Biotechnology), raised against a C-terminal sequence
of human Brachyury, performed best in chromatin immunopre-
cipitation. This antibody, raised against a divergent region of
Brachyury that does not include the T box, has been well
characterised in previous studies [78,79,80]. It gave the expected
pattern of staining in early mouse embryos (Fig. S6A,B) and
recognised Brachyury protein (of the correct size) in immunopre-
cipitation experiments followed by western blots (Fig. S6C). Such
experiments failed to detect Brachyury in ES cells in which
Brachyury expression was inhibited by use of ShRNA constructs
(Fig. S6D,E).
Whole-mount in situ hybridization
Wild type mouse embryos were collected from MF1 or 129
strains, and Brachyury mutant embryos from BTBR T
+tT/
J6BTBR T
+tT/J heterozygote crosses [39]. Embryos were fixed
overnight in 4% paraformaldehyde in phosphate-buffered saline
(PBS), after which they were dehydrated and stored in 100%
methanol at 220uC. The mouse Brachyury coding sequence was
subcloned into pCS2+ and used to generate a probe. An Axin2
probe was generated from IMAGE clone 1361800 (Geneservice), a
Wnt3a probe from IMAGE clone pENTR223.1 100015989 after
subcloning into pCS2+ (Table S7), and an Fgf8 probe from
IMAGE clone 6513131 (Geneservice) in pCMV-SPORT 6.1.
Digoxigenin labelled or fluorescein labelled antisense RNA probes
were generated using T7 RNA polymerase from linearised
templates and whole mount in situ hybridisation was performed
as described [81]. Alkaline phosphatase was detected using (i) BM
purple; (ii) 2-[4-iodophenyl]-3-[4-nitrophenyl]-5- phenyltetrazo-
lium chloride (250 mg/ml) plus magenta phosphate (250 mg/ml)
(INT/Mag); or (iii) nitro blue tetrazolium (175 mg/ml) plus 5-
bromo-4-chloro-3-indolyl phosphate (337.5 mg/ml) (NBT/BCIP)
(Roche). These gave dark blue, orange brown or purple staining
respectively. A final concentration of 5% polyvinyl alcohol (Sigma-
Aldrich) was used in the staining reaction.
Whole-mount immunohistochemistry
Embryos were fixed as described above and rehydrated to PBS
for staining. Free aldehyde groups were blocked using 1 M
glycine, embryos were washed in PBS/0.1% Tween 20 (PBST),
and endogenous peroxidases were blocked using 3% hydrogen
peroxide in PBS. Embryos were incubated overnight at 4uCi n
1:400 C19 antibody in PBST supplemented with 0.2% bovine
serum albumin (BSA) and 10% heat inactivated FBS. They were
then washed, incubated with 1:400 rabbit anti-goat biotinylated
IgG (E0466, Dako), and stained using Vectastain Elite ABC
substrate (Vector laboratories) with Sigma Fast Nickel Enhanced
DAB chromagen (Sigma).
In vitro translation and western blotting
Brachyury mRNA was synthesized using the pCS2+ construct
described above and the Ambion mMessage mMachine (Applied
Biosystems/Ambion). mRNA was translated in a rabbit reticulo-
cyte lysate (Promega). In vitro translation products and embryoid
body extracts were subjected to polyacrylamide gel electrophoresis
(PAGE) and western blots were performed using CAPS transfer
buffer (10 mM CAPS pH 11, 10% Methanol). Membranes were
blocked with 5% milk powder in PBST overnight, and antibodies
were diluted in the same solution. Washes were in PBST. Primary
antibodies were R&D Systems anti-T and SantaCruz anti-T (see
above). Both were used at a dilution of 1:250. Secondary
antibodies were HRP-linked SantaCruz D anti-goat IgG
(1:20,000) and HRP-linked Amersham NA934V anti-rabbit IgG
(1:100,000). All antibody incubations were 1 hour at room
temperature. Both endogenous and in vitro translated T proteins
were immunoprecipitated for western blotting using the Santacruz
Exactacruz D anti-goat system (SC-45041, Santa Cruz) to avoid
detection of heavy and light chains of the IP antibody. Detection
used the Pierce Supersignal West Dura Extended Duration
Substrate (Thermo Scientific).
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Chromatin immunoprecipitation/location analysis was based
on the Agilent Mammalian ChIP-chip Protocol, incorporating the
Whole Genome Amplification GenomePlex Kit (Sigma) [82].
Intact EBs (1.5610
9 cells) were fixed in 1 M formaldehyde for
20 min when Brachyury expression was at its highest level (usually
after 4 days of differentiation). This was followed by quenching
and isolation of nuclei. Our protocol differs from a previously-
published procedure [83] in that EBs are not disrupted before
fixation. Nuclei were sonicated using a Misonix 3000 ultrasoni-
cator to create fragments of 500 bp, and these were immunopre-
cipitated using polyclonal goat anti-Brachyury C-19 (Santa Cruz
Biotechnology) or normal goat IgG (Santa Cruz Biotechnology) as
an isotype control. Following washing and elution steps, cross-links
were reversed overnight at 65uC. Samples were analysed by
promoter-specific primers or amplified by GenomePlex whole
genome amplification for microarray studies.
Chromatin immunoprecipitation (human ESCs)
ChIP was performed as previously described [83] with some
modifications. Briefly, H9 hESCs (one confluent 10 cm dish) were
collected after 36 hr of culture in FLyB medium [41], when
BRACHYURY expression peaked. Cells were fixed as described
[83], the nuclei were isolated and sonicated using a Misonix 4000
to obtain DNA fragments of around 1000 bp. Samples were
incubated at 4uC overnight using 10 mg of an anti-BRACHYURY
goat IgG (R&D systems) and with10 mg of a non-specific goat IgG
as a control. The chromatin was immunoprecipitated by adding
100 ml of Protein G Dynabeads (Invitrogen), then incubating at
4uC 1 h, and collecting the beads using a magnetic rack. After
washing the beads, the chromatin was eluted and the crosslinking
was reversed at 65uC overnight. Samples were then treated with
RNAse and Proteinase K and the DNA was extracted by phenol/
chloroform, ethanol-precipitated and finally eluted in nuclease-free
water. This experiment was repeated three times with similar
results.
Verification of target enrichment was performed on a selection
of targets using genomic quantitative PCR. DNA fragments were
amplified using Fast SYBRH Green Master Mix (Applied
Biosystems) according to manufacturers instructions on a 7500
Fast Real-Time PCR System (Applied Biosystems). Promoter
specific primers (Table S8) were designed to amplify the
homologous regions of mouse T-binding sites (AXIN2, FGF8,
JUP and WNT3A). NCAPD2 was used as a negative control gene.
Microarray hybridization, analysis and verification of
binding targets
Agilent Technologies mouse promoter 244K (G4490A) 60-mer
oligonucleotide arrays (‘‘chips’’) covering 17,000 mouse genes and
extending 5.5 kb upstream and 2.5 kb downstream of transcrip-
tional start sites were hybridized with 5 mg amplified chromatin
per sample. Arrays were annotated to NBI35.1 of the mouse
genome. Immunoprecipitated (or isotype control) and total input
samples were labelled with Cy5 or Cy3 respectively. Hybridiza-
tions were performed and analysed in triplicate using indepen-
dently differentiated cultures. The isotype control experiment was
performed once to confirm no significant enrichment over input
chromatin (data not shown).
Microarrays were scanned using an Agilent scanner to a
resolution of 5 mm. Data were extracted using Agilent G2567AA
Feature Extraction Software (v.9.1). The significance of binding
events was determined using Agilent Chip Analytics 1.3 software.
Initial analysis was done using Chip Analytics defaults settings and
then further filtered using the parameters P(x) ,0.01 and P(x)
,0.005. The confidence of binding calls is represented as a P-
value: P(x) defines the value for each probe, and P(x) uses the
intensities of neighbouring probes to assess peak shape, in an effort
to eliminate false positives. Original raw data files can be accessed
from GEO Gene Expression Omnibus http://www.ncbi.nlm.nih.
gov/geo (accession GSM417692/GSM417704 for design 1 and 2
Brachyury data; GSM417714/GSM417756 for design 1 and 2
isotype control data).
Verification of enrichment was performed on a selection of
targets using promoter specific genomic quantitative PCR.
Promoter specific primers (Table S8) were designed so as to span
bound peaks using mouse build mm8 promoter sequence retrieved
from the UCSC genome browser (http://genome.ucsc.edu/).
Negative control genes from the list not called as bound were
included. Results were expressed relative to input chromatin
divided by relative enrichment for the isotype control antibody.
Bioinformatic analyses and Motif Finding
The GOToolBox (http://burgundy.cmmt.ubc.ca/GOToolBox/)
[84] wasused to access Gene Ontology(GO)resources andtosearch
for any functional bias in our dataset. The Benjamini and Hochberg
multiple testing correction was applied to assess the significance of
enrichment ratios. Target probes and surrounding promoter
sequences were scanned for the published consensus in vitro T-box
binding motif TCACACCT [17,18] using NestedMICA http://
www.sanger.ac.uk/Software/analysis/nmica/index.shtml [85]. We
also used Regulatory Sequence Analysis Tools (RSAT) http://rsat.
ulb.ac.be/rsat/[86],to scaneach target geneovera region 25k bt o
+1 kb relative to its ATG for over-represented cis-regulatory
modules, applying background models and taking promoter
sequences from 400 random mouse promoters as the control set.
Sequences representing enriched motifs were then stacked into
positional weight matrices and converted to sequence logos using
WebLogo (http://weblogo.berkeley.edu/logo.cgi) [87].
Electrophoretic mobility shift assays
The T domain of mouse Brachyury was amplified by PCR
(primer sequences in Table S7) and inserted in-frame into the
glutathione-S-transferase (GST) fusion vector pGEX-6P-1. The
fusion protein was expressed in E. coli by isopropyl-b-D-
thiogalactoside induction and purified at 4uC using GSTrap FF
columns and Pre-Scission Protease (GE Healthcare), leaving only a
glycine and a proline residue attached to the protein. This was
concentrated using Amicon Ultra 4 columns (Millipore), and the
identity of the resulting protein was confirmed by SDS PAGE and
mass spectrometry.
Double stranded oligomers containing (i) the core Brachyury
consensus binding sequence TCACACCT, (ii) a simple AC repeat,
or (iii) the core Brachyury sequence together with the AC repeat,
and mutated versions of each, had identical BglII/BamH1 59
overhangs (Table S7). These were PAGE purified, annealed, and
end-labelled with [a-
32P] dCTP using Klenow fragment. Unin-
corporated nucleotides were removed using Sephadex G-50
columns (GE Healthcare). Binding reactions were incubated on
ice for 40 minutes in 16EMSA binding buffer (25 mM HEPES
pH8.0, 100 mM KCl, 1 mM DTT, 0.1% NP-40, 5% glycerol,
10 mM EDTA), 0.5% milk powder and 50 ng/ml dI/dC using
30,000 cpm/ml and 8–10 fmol labelled oligomer. Competition
reactions using 4 pmol cold oligomers were pre-incubated for
10 min on ice. In supershift experiments goat polyclonal anti-
Brachyury N19 antibody (SC-17743, Santa Cruz) was added after
binding and then incubated a further 20 min on ice.
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Figure S1 Validation of targets. Box plot showing genomic
quantitative PCR of bound promoter regions for targets Axin2,
Foxe1, Mapre2, Nkx2.6, Pax3, Rttn, Van Gogh and the published
target Nanog, and unbound or negative promoter regions Nanog 39,
1700010C24Rik and beta actin. Boxes represent the interquartile
range, the upper edge being the 75
th percentile and lower edge the
25
th percentile. The whiskers show the minimum and maximum
values. Values above the line are enriched in chromatin
immunoprecipitations. Data were obtained from five independent
chromatin immunoprecipitations. Probes recognising Nanog were
not present on Agilent 244K promoter arrays.
(TIF)
Figure S2 Functional analysis of target genes. Bar charts
show Gene Ontology (GO) annotations for (A) biological process;
(B) cellular component; and (C) molecular function using the
GOToolBox. Horizontal bars represent enrichment ratio (ob-
served frequency/expected frequency) and vertical axis gives the
GO term followed by the GO identification number in brackets
and hierarchy level. Colour bars indicate statistical significance.
GO terms related to the function of Brachyury are highlighted in
red boxes.
(TIF)
Figure S3 Interaction of the mouse Brachyury T domain
with DNA. (A) Sequences surrounding bound probes are
enriched for an (AC)n repeat relative to their genomic neighbours.
The motif was generated using the NestedMICA position weight
matrix. This may represent a secondary Brachyury recognition
motif. (B) Electrophoretic mobility shift assays. Panel a: Binding
reactions using
32P-labelled TCACACCT. Lane 1, no protein;
lane 2, control protein derived from empty vector; lanes 3–6,
mouse T domain protein: lane 4 includes excess unlabelled probe;
lane 5 includes excess unlabelled mutated probe; lane 6 is a
‘supershift’ using anti-T N-19 (SC-17743, Santa Cruz). Notice that
the Brachyury T domain binds the T site oligonucleotide and that
binding is competed by cold wild-type oligonucleotide but not by a
mutated oligonucleotide. Panel b: Lanes 7–9 include
32P-labelled
TCACACCT; lane 10 uses the indicated mutated version of this
oligonucleotide. Note that the Brachyury T domain does not bind
the mutated oligonucleotide. Panel c: Binding reaction using a
32P-
labelled AC repeat oligonucleotide. Lanes 11–13 as panel a; lane
14 includes excess unlabelled probe; lane 15 includes excess of an
unlabelled mutated probe; lane 16 is a ‘supershift’. Notice that the
Brachyury T domain binds the AC repeat oligonucleotide weakly
but that binding does not seem to be competed by cold wild-type
oligonucleotide. The complex however is ‘supershifted’ using the
Brachyury antibody. Panel d: Binding reactions using a
32P
labelled motif that includes both the T site TCACACCT and an
AC repeat. Lanes 17–20 show that Brachyury binds this
oligonucleotide, and that binding is competed by cold wild-type
oligonucleotide. Lanes 21 and 22 show that binding is not
competed significantly by unlabelled oligonucleotides in which
either motif is mutated. Lane 23 shows a ‘supershift’. Experiments
in (a–d) were performed under identical conditions and exposed
for the same times.
(TIF)
Figure S4 The expression domains of Brachyury, Wnt3a
and Axin2 overlap in E7.75 mouse embryos. (A) Expression
of Axin2 analysed using a fluorescein labelled antisense probe
detected with NBT/BCIP (purple). (B) The embryo in (A) analysed
using a digoxigenin labelled antisense Brachyury probe detected
with INT/Mg phosphate (brown). (C) Expression of Wnt3a
analysed using a fluorescein labelled antisense probe detected
with NBT/BCIP (purple). (D) The embryo in (C) analysed using a
digoxigenin labelled antisense Brachyury probe detected with INT/
Mg phosphate (brown). All embryos orientated as in (A). Scale bars
are 200 mm.
(TIF)
Figure S5 The expression domains of Brachyury and
Fgf8 overlap in the primitive streak of E7.75 mouse
embryos. (A). Expression of Fgf8 analysed using a fluorescein
labelled antisense probe detected with NBT/BCIP (purple). (B).
The embryo in (A) analysed using a digoxigenin labelled antisense
Brachyury probe detected with INT/Mg phosphate (brown). Black
bars are 200 mm.
(TIF)
Figure S6 Verification of anti Brachyury antibody. (A)
Immunohistochemistry of E9.5 embryo using Santa Cruz anti-
human T C19 with nickel enhanced DAB substrate. Staining is
present in the notochord (arrowhead), pre-somitic mesoderm
(arrow) and tailbud. Staining was absent in controls in which
primary or secondary antibodies were omitted. (B) Expression of
Brachyury RNA in an E9.5 embryo studied by in situ hybridisation.
Note similarity to (A). Bars in (A) and (B) represent 250 mm. (C)
Western blot testing antibody specificity. Size markers are shown
to the left. Lane 1: Mouse Brachyury reticulocyte lysate translation
product; lane 2: unprogrammed reticulocyte lysate translation
product; lane 3: Immunoprecipitated material derived from
Brachyury reticulocyte lysate translation product; lane 4: Super-
natant of immunoprecipitated material in lane 3; lane 5:
Immunoprecipitated material derived from day 4 embryoid
bodies; lane 6: Supernatant of immunoprecipitated material in
lane 5; lane 7: Immunoprecipitated material derived from day 4
embryoid bodies, having omitted first antibody; lane 8: Superna-
tant of immunoprecipitated material in lane 7. All immunopre-
cipitations used Santa Cruz anti-T C19. Western blots used R&D
Systems anti-T as a primary antibody and SantaCruz D anti-goat
IgG HRP linked secondary antibody. (D) Strategy to create ES cell
clones lacking Brachyury. Clones were created using 65 bp
ShRNA duplexes targeting the first exon of Brachyury (T).
Sequences were inserted into the XhoI/HindIII site of the pSingle
ShRNA vector (Clontech) which includes a tetracyclin-controlled
transcriptional repressor that in turn regulates the expression of
the ShRNA sequence. Selection of stable lines is achieved by
culture in G418 and induction of ShRNA expression occurs
through addition of 1 mg/ml doxycycline. (E) Western blot analysis
of day 5 embryoid body extracts from clones containing ShRNA
constructs targeted to Brachyury exon 1 (T1) or a scrambled version
of this sequence (Ts), either treated with doxycycline (+) or left
untreated (2). Samples were immunoprecipitated as in (C). Note
loss of Brachyury band in lane 3.
(TIF)
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